HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA)

Autor: J. Levy, A. Alimenti, M. Della Negra, W. Queiroz, Y. C. Lian, C. S. Soares, D. Zarowny, S. Korasheh, J. Forbes, T. Jadavji, W. Vaudry, F. Mechinaud, S. Billaudel, S. Auger, J. Nicolas V. Wahn, S. Kropp, C. Bode, A. Bru Capdeville, T. Niehues, D. Richter, S. Freude, G. Horneff, K. Balley, N. Vente, A. Seibt, C. Dammann, A. Sobanjo, G. Notheis, B. Heeren, B. Hinkelmann, K. Butler, E. Hayes, C. Giaquinto, S. Cozzani, V. Giacomet, E. Ruga, O. Rampon, F. Zacchello, L. Chieco Bianchi, A. de Rossi, A. De Manzini, C. Salvatore, A. Mazza, M. Duse, A. Soresina, M. Pernici, S. Timpano, A. Manca, A. Loy, A. de Maria, A. Plebani, M. G. Clerici, S. Alberti, M. Bray, R. Pinzani, G. Castelli Gattinara, S. Bernardi, S. Scaccia, S. Liviadiotti, A. Krzysztofiak, A. Angioni, P. Orlandi, M. Cellini, C. Baraldi, M. Portolani, P. A. Tovo, E. Palomba, D. Caselli, A. Maccabruni, S. Russo, A. Castaldo, P. Osimani, M. Vignini, H. Scherpbier, P. Leeuwen, A. Delgado, J. Aristegui, R. Cisterna, D. Suarez, I. De José Gomez, M. Herranz Aguirre, M. C. Garcia Rodriguez, J. Echeverria Lecuona, E. Perez Trallero, P. Echaniz Aizpuru, P. Martin Fontelos, M. J. Mellado Pena, A. Bernal, J. M. Perez Gonzales, M. Gracia Casanova, J. A. Leon Leal, J. Ruiz Contreras, J. T. Ramos Amador, C. Canosa, A. Mur Sierra, L. Ciria Calavia, C. Rodrigo, C. Fortuny Guasch, A. Bohlin, D. Nadal, J. Mok, K. Barlow, S. King, J. Hailey, J. Isiah, K. Reynolds, K. Barclay, F. Mitchell, C. Smith, S. Burns, J. Evans, M. S. Walters, R. Booy, S. Marriage, H. Lyall, G. Tudor Williams, J. Weber, C. Stainsby, S. Bingham, S. Galpin, D. Gibb, V. Novelli, J. Crawley, R. Gilbert, N. Klein, L. Nokes, K. Formica, S. Kaye, M. Sharland, W. Faulkner, K. Sloper, GUARINO, ALFREDO

Publikováno v: AIDS (London, England). 12(4)

BACKGROUND: Plasma HIV-1 RNA levels are high in vertically infected infants. Information in older children is limited, particularly in those who have not received antiretroviral therapy. OBJECTIVES: To describe the relationships between HIV-1 RNA, ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c2b8c0deb8dc1aeffe927d81fd0746f8
https://pubmed.ncbi.nlm.nih.gov/9520161

Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

Autor: Aboulker, J. P., Babiker, A., Darbyshire, J. H., Debre, M., Giaquinto, C., Gibb, D. M., Harper, L., Newberry, A., Saidi, Y., Levy, J., Della Negra, M., Forbes, J., Vaudry, W., Mechinaud, F., Nicolas, J., Wahn, V., Dammann, C., Notheis, G., Hinkelmann, B., Butler, K., De Manzini, A., Mazza, A., Duse, Marzia, Loy, A., Plebani, A., Castelli Gattinara, G., Cellini, M., Palomba, E., Caselli, D., Guarino, A., Osimani, P., Scherpbier, H., Delgado, A., Gomez, I. D., Lecuona, J. E., Pena, M. J. M., Baselga, C., Leal, J. A. L., Amador, J. T. R., Canosa, C., Sierra, A. M., Calavia, L. C., Rodrigo, C., Guasch, C. F., Bohlin, A., Nadal, D., Mok, J., Lyall, H., Novelli, V., Sharland, M., Sloper, K.

Publikováno v: Archives of Disease in Childhood. 84:230-236

A total of 195 children were randomised to zidovudine (immediate) or matching placebo (deferred) in a multicentre double blind trial in vertically HIV infected children with early disease (the PENTA 1 trial). Median follow up in the blinded phase was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b33de229726b0a50b06aa10ce38fcde
https://doi.org/10.1136/adc.84.3.230